These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11943349)

  • 1. Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma.
    Lemeta S; Aalto Y; Niemelä M; Jääskeläinen J; Sainio M; Kere J; Knuutila S; Böhling T
    Cancer Genet Cytogenet; 2002 Mar; 133(2):174-8. PubMed ID: 11943349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
    Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
    J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
    Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL).
    Decker HJ; Klauck SM; Lawrence JB; McNeil J; Smith D; Gemmill RM; Sandberg AA; Neumann HH; Simon B; Green J
    Cancer Genet Cytogenet; 1994 Oct; 77(1):1-13. PubMed ID: 7923076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.
    Wait SD; Vortmeyer AO; Lonser RR; Chang DT; Finn MA; Bhowmick DA; Pack SD; Oldfield EH; Zhuang Z
    Ann Neurol; 2004 Feb; 55(2):236-40. PubMed ID: 14755727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
    Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
    Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
    Vortmeyer AO; Huang SC; Pack SD; Koch CA; Lubensky IA; Oldfield EH; Zhuang Z
    Oncogene; 2002 Feb; 21(8):1167-70. PubMed ID: 11850836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
    Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
    J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
    Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
    Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.